missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human LAMTOR5 Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Conditionnement:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (76%), Rat (76%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-52352 (PA5-52352. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
HBXIP, also named as XIP, belongs to the HBXIP family. It is originally identified by its interaction with the C-terminus of hepatitis B virus (HBV) X protein (HBx). HBXIP is a regulator of centrosome dynamics and cytokinesis. HBXIP is able to up-regulate S100A4 though activating STAT4 and inducing DNA methylation of PTEN. HBXIP is a cellular 18kd protein and cytoplasm stain.
Spécification
Spécification
| Accession Number | O43504 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 10542 |
| Name | Human LAMTOR5 Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 1110003H18Rik; HBV X-interacting protein; HBV X-interacting protein homolog; HBx-interacting protein; HBX-interacting protein homolog; HBXIP; hepatitis B virus x interacting protein; Hepatitis B virus X-interacting protein; hepatitis B virus x-interacting protein (9.6 kD); hepatitis B virus X-interacting protein homolog; LAMTOR5; Late endosomal/lysosomal adaptor and MAPK and MTOR activator 5; late endosomal/lysosomal adaptor, MAPK and MTOR activator 5; MGC71071; ragulator complex protein LAMTOR5; XIP |
| Common Name | LAMTOR5 |
| Afficher plus |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu